The global cellular health screening market was valued at USD 3.30 billion in 2024 and is expected to grow to USD 3.59 billion in 2025, reaching USD 6.50 billion by 2032. This growth reflects a compound annual growth rate (CAGR) of 8.9% over the forecast period. In 2024, North America led the market, accounting for a dominant share of 47.27%.